237 related articles for article (PubMed ID: 32948514)
21. Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy.
Reier-Nilsen T; Michelsen MM; Lødrup Carlsen KC; Carlsen KH; Mowinckel P; Nygaard UC; Namork E; Borres MP; Håland G
Allergy; 2019 Feb; 74(2):337-348. PubMed ID: 30225844
[TBL] [Abstract][Full Text] [Related]
22. Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.
Sampson HA; Shreffler WG; Yang WH; Sussman GL; Brown-Whitehorn TF; Nadeau KC; Cheema AS; Leonard SA; Pongracic JA; Sauvage-Delebarre C; Assa'ad AH; de Blay F; Bird JA; Tilles SA; Boralevi F; Bourrier T; Hébert J; Green TD; Gerth van Wijk R; Knulst AC; Kanny G; Schneider LC; Kowalski ML; Dupont C
JAMA; 2017 Nov; 318(18):1798-1809. PubMed ID: 29136445
[TBL] [Abstract][Full Text] [Related]
23. Oral immunotherapy for the treatment of peanut allergy: is it ready for prime time?
Wood RA; Sampson HA
J Allergy Clin Immunol Pract; 2014; 2(1):97-8. PubMed ID: 24565776
[No Abstract] [Full Text] [Related]
24. Individually dosed omalizumab: an effective treatment for severe peanut allergy.
Brandström J; Vetander M; Lilja G; Johansson SG; Sundqvist AC; Kalm F; Nilsson C; Nopp A
Clin Exp Allergy; 2017 Apr; 47(4):540-550. PubMed ID: 27883239
[TBL] [Abstract][Full Text] [Related]
25. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.
Chu DK; Wood RA; French S; Fiocchi A; Jordana M; Waserman S; Brożek JL; Schünemann HJ
Lancet; 2019 Jun; 393(10187):2222-2232. PubMed ID: 31030987
[TBL] [Abstract][Full Text] [Related]
26. Oral Immunotherapy in Japanese Children with Anaphylactic Peanut Allergy.
Nagakura KI; Sato S; Yanagida N; Nishino M; Asaumi T; Ogura K; Ebisawa M
Int Arch Allergy Immunol; 2018; 175(3):181-188. PubMed ID: 29339650
[TBL] [Abstract][Full Text] [Related]
27. Delayed symptoms and orthostatic intolerance following peanut challenge.
Turner PJ; Ruiz-Garcia M; Patel N; Abrantes G; Burrell S; Vazquez-Ortiz M; Skypala I; Durham SR; Boyle RJ
Clin Exp Allergy; 2021 May; 51(5):696-702. PubMed ID: 33715235
[TBL] [Abstract][Full Text] [Related]
28. Correlation of negative skin-prick test results for tree nuts and successful tree nut challenges among children with peanut allergy.
Randhawa I; Morphew T; Marsteller NL
Allergy Asthma Proc; 2018 Nov; 39(6):456-460. PubMed ID: 30401323
[No Abstract] [Full Text] [Related]
29. The longitudinal impact of probiotic and peanut oral immunotherapy on health-related quality of life.
Dunn Galvin A; McMahon S; Ponsonby AL; Hsiao KC; Tang MLK;
Allergy; 2018 Mar; 73(3):560-568. PubMed ID: 29052245
[TBL] [Abstract][Full Text] [Related]
30. Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
Pongracic JA; Gagnon R; Sussman G; Siri D; Oriel RC; Brown-Whitehorn TF; Green TD; Campbell DE; Anvari S; Berger WE; Bird JA; Chan ES; Cheema A; Chinthrajah RS; Chong HJ; Dowling PJ; Fineman SM; Fleischer DM; Gonzalez-Reyes E; Kim EH; Lanser BJ; MacGinnitie A; Mehta H; Petroni D; Rupp N; Schneider LC; Scurlock AM; Sher LD; Shreffler WG; Sindher SB; Stillerman A; Wood R; Yang WH; Bois T; Sampson HA; Bégin P
J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1864-1873.e10. PubMed ID: 34848381
[TBL] [Abstract][Full Text] [Related]
31. Patterns of Carriage of Prescribed Adrenaline Autoinjectors in 10- to 14-Year-Old Food-Allergic Students: A Population-Based Study.
Robinson M; Koplin JJ; Field MJ; Sasaki M; Peters RL; McWilliam V; Sawyer SM; Patton GC; Vuillermin PJ; Douglass J; Gurrin LC; Tang MLK; Dharmage SC; Allen KJ;
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):437-443. PubMed ID: 30031901
[TBL] [Abstract][Full Text] [Related]
32. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
[TBL] [Abstract][Full Text] [Related]
33. A majority of parents of children with peanut allergy fear using the epinephrine auto-injector.
Chad L; Ben-Shoshan M; Asai Y; Cherkaoui S; Alizadehfar R; St-Pierre Y; Harada L; Allen M; Clarke A
Allergy; 2013 Dec; 68(12):1605-9. PubMed ID: 24410784
[TBL] [Abstract][Full Text] [Related]
34. Parental satisfaction with oral peanut food challenges; perception of outcomes and impact on management of peanut allergy.
Nguyen M; Wainstein BK; Hu W; Ziegler JB
Pediatr Allergy Immunol; 2010 Dec; 21(8):1119-26. PubMed ID: 20444148
[TBL] [Abstract][Full Text] [Related]
35. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
Greenhawt M; Sindher SB; Wang J; O'Sullivan M; du Toit G; Kim EH; Albright D; Anvari S; Arends N; Arkwright PD; Bégin P; Blumchen K; Bourrier T; Brown-Whitehorn T; Cassell H; Chan ES; Ciaccio CE; Deschildre A; Divaret-Chauveau A; Dorris SL; Dorsey MJ; Eiwegger T; Erlewyn-Lajeunesse M; Fleischer DM; Ford LS; Garcia-Lloret M; Giovannini-Chami L; Hourihane JO; Jay N; Jones SM; Kerns LA; Kloepfer KM; Leonard S; Lezmi G; Lieberman JA; Lomas J; Makhija M; Parrish C; Peake J; Perrett KP; Petroni D; Pfützner W; Pongracic JA; Quinn P; Robison RG; Sanders G; Schneider L; Sharma HP; Trujillo J; Turner PJ; Tuttle K; Upton JE; Varshney P; Vickery BP; Vogelberg C; Wainstein B; Wood RA; Bee KJ; Campbell DE; Green TD; Rouissi R; Peillon A; Bahnson HT; Bois T; Sampson HA; Burks AW
N Engl J Med; 2023 May; 388(19):1755-1766. PubMed ID: 37163622
[TBL] [Abstract][Full Text] [Related]
36. Peanut-induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry.
Maris I; Dölle-Bierke S; Renaudin JM; Lange L; Koehli A; Spindler T; Hourihane J; Scherer K; Nemat K; Kemen C; Neustädter I; Vogelberg C; Reese T; Yildiz I; Szepfalusi Z; Ott H; Straube H; Papadopoulos NG; Hämmerling S; Staden U; Polz M; Mustakov T; Cichocka-Jarosz E; Cocco R; Fiocchi AG; Fernandez-Rivas M; Worm M;
Allergy; 2021 May; 76(5):1517-1527. PubMed ID: 33274436
[TBL] [Abstract][Full Text] [Related]
37. Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis.
Patel N; Adelman DC; Anagnostou K; Baumert JL; Blom WM; Campbell DE; Chinthrajah RS; Mills ENC; Javed B; Purington N; Remington BC; Sampson HA; Smith AD; Yarham RAR; Turner PJ
J Allergy Clin Immunol; 2021 Jun; 147(6):2249-2262.e7. PubMed ID: 33571537
[TBL] [Abstract][Full Text] [Related]
38. The Health and Economic Outcomes of Peanut Allergy Management Practices.
Shaker M; Greenhawt M
J Allergy Clin Immunol Pract; 2018; 6(6):2073-2080. PubMed ID: 29751153
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Severe Reactions during Double-Blind Placebo-Controlled Food Challenges.
Yanagida N; Sato S; Asaumi T; Ogura K; Ebisawa M
Int Arch Allergy Immunol; 2017; 172(3):173-182. PubMed ID: 28380495
[TBL] [Abstract][Full Text] [Related]
40. Oral Immunotherapy for Peanut Allergy.
Anagnostou K; Clark A
Annu Rev Med; 2016; 67():375-85. PubMed ID: 26332004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
